ACSL3 and cancer: Lipid metabolism reprogramming is a hallmark of cancer [41–45]and we observed that SNRPB knockdown reduced triglyceride, cholesterol, and free fatty acid levels in HCC cells by downregulating key metabolic enzymes such as ACLY, FASN, and ACSL3 46, 47.